Age-related Differences in Growth Hormone (GH) Regulation during Strenuous Exercise

Abstract

This study was designed to investigate the central neuroendocrine mechanisms by which exercise (EX) stimulates growth hormone (GH) release as a function of age. Twelve male subjects, six in their early-to-mid twenties and six in their late sixties or seventies, received a strong GH stimulus either as incremental EX until volitional exhaustion or by administration of GHRH alone or Hex alone two hours after a presumed maximal GH response to combined administration of GHRH plus hexarelin (Hex). Total GH availability was calculated as area under the curve (AUC) over time periods 0 - 120 and 120 - 240 min. The mean AUC in µg/l × 120 min to GHRH+Hex in the younger group was approximately twice that in the older group (11,260, range 3,947 - 19,007 vs. 5,366, range 2,262 - 8,654). In younger males, the mean AUC to EX (509, range 0 - 1,151) was larger than to GHRH (119, range 0 - 543), but less than that to Hex (919, range 0 - 1,892). In the older group, GH responses to EX and GHRH were abolished (mean AUC: 112, range 0 - 285, and 156, range 30 - 493), respectively) in contrast to the response to Hex (1,077, range 189 - 1,780). These data indicate that maximal GH stimulation by GHRH+Hex results in greater desensitization of GHRH compared to Hex, irrespective of age. We postulate that the abolished responsiveness of GH to EX in older group is due to insufficient disinhibition of hypothalamic somatostatin activity and desensitization of GHRH, while the preserved activity of a central Hex-related pathway is not involved. The GH response to EX in younger males is due to complete inhibition of somatostatin activity and stimulation of a central Hex-related pathway in spite of GHRH desensitization. We conclude that a central Hex-related pathway is the primary factor for EX-induced GH release only in younger males.

Key words

Aging · Pituitary responsiveness · Secretagogues · Cycle Ergometry · Desensitization

References

• 1 Hagberg J M, Seals D R, Yerg J E, Gavin J, Gingerich R, Premachandra B, Holloszy J O. Metabolic responses to exercise in young and old athletes and in sedentary men.  J Appl Physiol. 1988;  65 900-908
• 2 Pyka G, Wiswell R A, Marcus R. Age-dependent effect of resistance exercise on growth hormone secretion in people.  J Clin Endocrinol Metab. 1992;  75 404-407
• 3 Lamberts S WJ, van den Beld A W, Van der Lely A-J. The endocrinology of aging.  Science. 1997;  278 419-424
• 4 Casanueva F F, Villanueva L, Cabranes J A, Cabezas-Cerrato J, Fernandez-Cruz A. Cholinergic mediation of growth hormone secretion elicited by arginine, clonidine and physical exercise in man.  J Clin Endocrinol Metab. 1984;  59 526-530
• 5 Few J D, Davies C T. The inhibiting effect of atropine on growth hormone release during exercise.  Eur J Appl Physiol. 1980;  43 221-228
• 6 Maas H CM, de Vries W R, Maitimu I, Bol E, Bowers C Y, Koppeschaar H PF. Growth hormone (GH) responses during strenuous exercise: the role of GH-releasing hormone (GHRH) and GH-releasing peptide-2 (GHRP-2).  Med Sci Sports Exerc. 2000;  32 1226-1232
• 7 Nooitgedagt A, Koppeschaar H PF, de Vries W R, Sidorowicz A, Klok L J, Dieguez C, Mallo F. Influence of endogenous cholinergic tone and growth hormone-releasing peptide-6 on exercise induced growth hormone release.  Clin Endocrinol. 1997;  46 195-202
• 8 Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo M, Kangawa K. Ghrelin is a growth hormone-releasing acylated peptide from stomach.  Nature. 1999;  402 656-660
• 9 Dieguez C, Casanueva F F. Ghrelin: a step forward in the understanding of somatotroph cell function and growth regulation.  Eur J Endocrinol. 2000;  142 413-417
• 10 Deghenghi R, Cananzi M M, Torsello A, Battisti C, Müller E E, Locatelli V. GH-releasing activity of hexarelin, a new growth hormone releasing peptide, in infant and adult rats.  Life Sci. 1994;  54 1321-1328
• 11 Imbimbo B P, Mant T, Edwards M, Amin D, Dalton N, Boutignon F, Lenaerts V, Wuthrich P, Deghenghi R. Growth hormone releasing activity of hexarelin in humans: a dose-response study.  Eur J Clin Pharmacol. 1994;  46 421-425
• 12 Bowers C Y, Sartor A O, Reynolds G A, Badger T M. On the action of the growth hormone-releasing hexapeptide, GHRP.  Endocrinol. 1991;  128 2027-2035
• 13 Bowers C Y, Reynolds G A, Durham D, Barrera C M, Pezzoli S S, Thorner M O. Growth hormone (GH)-releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone.  J Clin Endocrinol Metab. 1990;  70 975-982
• 14 Massoud A F, Hindmarsh P C, Matthews D R, Brook C GD. The effect of repeated administration of hexarelin, a growth hormone releasing peptide, and growth hormone releasing hormone on growth hormone responsivity.  Clin Endocrinol. 1996;  44 555-562
• 15 Harrela M, Qiao Q, Koistinen R, Tuomilehto J, Nissinen A, Seppälä M, Leinonen P. High serum insulin-like growth factor binding protein-1 is associated with increased cardiovascular mortality in elderly men.  Horm Metab Res. 2002;  34 144-149
• 16 Arvat E, Gianotti L, Grottoli S, Imbimbo P, Lenaerts V, Deghenghi R, Camanni F, Ghigo E. Arginine and growth hormone-releasing hormone restore the blunted growth hormone-releasing activity of hexarelin in elderly subjects.  J Clin Endocrinol Metab. 1994;  79 1440-1443
• 17 DeBell W K, Pezzoli S S, Thorner M O. Growth hormone (GH) secretion during continuous infusion of GH-releasing peptide: partial response attenuation.  J Clin Endocrinol Metab. 1991;  72 1312-1316
• 18 Ghigo E, Arvat E, Gianotti L, Imbimbo B P, Lenaerts V, Deghenghi R, Camanni F. Growth hormone-releasing activity of Hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal and oral administration in man.  J Clin Endocrinol Metab. 71 994;  8 693-698
• 19 Ghigo E, Arvat E, Gianotti L, Grottoli S, Rizzi G, Ceda G P. Aging and growth hormone-releasing peptides. In: Bercu B, Walker R (eds) Growth Hormone Secretagogues. New York; Springer-Verlag 1996: 415-431
• 20 Pavlov E P, Harman S M, Merriam G R, Gelato M C, Blackman M R. Response of growth hormone (GH) and somatomedin-C to GH-releasing hormone in healthy aging men.  J Clin Endocrinol Metab. 1986;  62 595-600
• 21 Aleman A, de Vries W R, de Haan E HF, Verhaar H JJ, Samson M M, Koppeschaar H PF. Age-sensitive cognitive function, growth hormone and insulin-like growth factor 1 plasma levels in healthy older men.  Neuropsychobiol. 2000;  41 73-78
• 22 Camanni F, Ghigo E, Arvat E. Growth hormone-releasing peptides and their analogs.  Front Neuroendocrinol. 1998;  19 47-72
• 23 Shibasaki T, Hotta M, Masuda A, Imaki T, Obara N, Demura H, Ling N, Shizuma K. Plasma GH responses to GHRH and insulin-induced hypoglycemia in man.  J Clin Endocrinol Metab. 1985;  60 1265-1267
• 24 Valcavi R, Dieguez C, Page M D, Zini M, Casoli P, Portioli I, Scanlon M F. Alpha-2-adrenergic pathways release growth hormone via a non-GRF-dependent mechanism in normal human subjects.  Clin Endocrinol. 1988;  29 309-316
• 25 Gelato M C, Pescovitz D H, Cassorla F, Loriaux D L, Merriam G R. Dose-response relationships for the effects of GH-releasing factor 1-44 NH₂ in young adult men and women.  J Clin Endocrinol Metab. 1984;  59 197-203
• 26 Suri D, Hindmarsch P C, Matthews D R, Brain C E, Brook C GD. The pituitary gland is capable of responding to two successive doses of growth hormone releasing hormone (GHRH).  Clin Endocrinol. 1991;  34 13-17
• 27 Stachura M E, Tyler J M, Kent P G. Effect of growth hormone-releasing factor-44 upon release of concurrently synthesized hormone by perfused rat pituitary tissue.  Endocrinol. 1986;  119 1245-1253
• 28 Wise P M. Neuroendocrine correlates of aging. In: Conn PM, Freeman ME (eds) Neuroendocrinology in Physiology and Medicine. Totowa; Humana Press Inc 1999: 371-387
• 29 Marcell T J, Wiswell R A, Hawkins S A, Tarpenning K M. Age-related blunting of growth hormone secretion during exercise may not be solely due to increased somatostatin tone.  Metabol. 1999;  48 665-670
• 30 Jaffe C A, Demott-Friberg R, Barkan A L. Endogenous growth hormone (GH)-releasing hormone is required for GH responses to pharmacological stimuli.  J Clin Invest. 1996;  97 934-940
• 31 De Vries W R, Schers T J, Abdesselam S A, Maitimu I, Maas J CM, Koppeschaar H PF. High-intensity exercise enhances growth hormone (GH) secretion by a GHRH-dependent mechanism.  Med Sci Sports Exerc. 1998;  30 S49
• 32 Kallio J, Pesonen U, Karvonen M K, Kojima M, Hosoda H, Kangawa K, Koulu M. Enhanced exercise-induced GH secretion in subjects with Pro7 substitution in the prepro-NPY.  J Clin Endocrinol Metab. 2001;  86 5348-5352
• 33 Dall R, Kanaley J, Hansen T K, Moller N, Christiansen J S, Hosoda H, Kangawa K, Jorgensen J OL. Plasma ghrelin levels during exercise in healthy subjects and in growth hormone-deficient patients.  Eur J Endocrinol. 2002;  147 65-70